BioSpace News Archive

Adoption of Technology-Enabled Services and Dispensing Solutions Supports Autonomous Pharmacy Vision

HT Medical, a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery, today announced that it has changed its name to Xēnix Medical as part of a rebranding initiative.

Strong balance sheet: Approximately $110 million in cash and cash equivalents as of March 31, 2021 1 Company remains on-track for potential product approvals in US in August 2021 and in Europe in early 2022

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 million from a syndicate of leading life science investors in an oversubscribed financing round.

AVM Biotechnology announced today that the first cohort has been fully enrolled in their clinical study (NCT04329728 “The WWRD Study”). All three patients had failed multiple prior therapies, and one had failed two transplants.

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2021 on Wednesday, April 28, after the market closes.

Ironshore Pharmaceuticals Inc. announced the publication of an original paper in the Journal of Child and Adolescent Psychopharmacology that describes new data showing the effect of JORNAY PM® extended-release capsules CII on caregiver strain as measured by the Caregiver Strain Questionnaire.

Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed an Investigator-Initiated Study Agreement with the Cleveland Clinic Foundation (Cleveland Clinic).

Veristat , a scientific-minded, global clinical research organization (CRO), announced today that it transferred its majority ownership from Variance Development Partners to WindRose Health Investors (WindRose). WindRose invests exclusively in healthcare companies and has extensive experience across the healthcare services landscape

Anthem, Inc. announced that it will provide a $50 incentive to all associates who are fully vaccinated against COVID-19.